Nyrada
Menu
NYR:
Market Cap*:
Price Delay ~20min
Home
About Us
Company Overview
Board of Directors
Management
Scientific Advisory Board
Corporate Governance
Our Science
Lead Drug Development
Brain Injury Program
Cholesterol Lowering Program
Technical Glossary
Drug Development Pathway
Investors
Investor Welcome
ASX Announcements
Brain Injury Program
Cholesterol-Lowering Program
Financial Reports
Corporate Announcements
Investor Presentations
Share Price Information
Key Dates
Investors Glossary
Annual Reports
Analyst Reports
Annual General Meeting
Past Shareholder Meetings
News & Insights
Presentations & Interviews
Media
Newsletters
Publications
Contact Us
Contact Us
Working at Nyrada
Email Alerts
Investors
Home
>
Investors
>
ASX Announcements
Investor Welcome
ASX Announcements
Brain Injury Program
Cholesterol-Lowering Program
Financial Reports
Corporate Announcements
Investor Presentations
Share Price Information
Key Dates
Investors Glossary
Annual Reports
Analyst Reports
Annual General Meeting
Past Shareholder Meetings
ASX Announcements
Filter by Year:
2023
2022
2021
2020
20-Jan-2020
Becoming a substantial holder
17-Jan-2020
Nyrada Inc - Corporate Presentation
16-Jan-2020
NOX: Listing of Nyrada Inc. spin-off on ASX
16-Jan-2020
NYR Commences Trading on the ASX
16-Jan-2020
Becoming a substantial holder
16-Jan-2020
Becoming a substantial holder
16-Jan-2020
Initial Director's Interest Notice
16-Jan-2020
Initial Director's Interest Notice
16-Jan-2020
Initial Director's Interest Notice
16-Jan-2020
Initial Director's Interest Notice
Previous
1
2
3
4
5
6
7
8
Next
